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Tobacco users are much more susceptible to 
dental caries and periodontal diseases than non-
tobacco users. Research suggests that this increased 
susceptibility may be due in part to nicotine, 
a primary active component of tobacco. Five 
bacterial species and one yeast species commonly 
found in the human oral cavity, Lactobacillus casei, 
Actinomyces viscosus, Actinomyces naeslundii, 
Rothia dentocariosa, Enterococcus faecalis, and 
Candida albicans respectively, were utilized to 
investigate if any correlation existed between 
exposure to various concentrations of nicotine 
ranging from 0 to 32 mg/ml and the growth of 
each microorganism. The minimum inhibitory 
concentration (MIC), minimum biofilm inhibitory 
concentration (MBIC), and planktonic growth were 
measured. The MIC was determined to be 16 mg/
ml for all organisms except E. faecalis, which had 
an MIC of 32 mg/ml. Nicotine had a varying effect 
on planktonic growth across the different species.  
A distinct upward trend in biofilm formation 
was found in A. viscosus, L. casei, E. faecalis, 
and C. albicans through 8 mg/ml. Nicotine also 
enhanced R. dentocariosa biofilm formation in 
all concentrations through 8 mg/ml but was most 
enhanced at 1 mg/ml. Alternatively, A. naeslundii 
exhibited a complete downward trend through 32 
mg/ml.  The MBIC was found to be 16 mg/ml in all 
organisms studied.  These findings further support 
research suggesting that the increased susceptibility 
to oral health diseases experienced by tobacco 
users may be caused in part by an upregulation in 
biofilm formation of these oral pathogens.
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INTRODUCTION
Periodontal disease is a condition that 
causes inflammation of the gums including 
diseases such as gingivitis, in which 
gums become swollen and bleed easily. 
Periodontitis, another form of periodontal 
disease, is an advanced form of gingivitis 
in which the gums pull away from the 
teeth and form pockets where dental plaque 
begins to grow. This infection can lead to 
both severe tissue and bone damage due 
to the increased exposure to previously 
protected areas. Periodontal disease is also 
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closely linked with dental caries. The 
occurrence of both periodontal disease 
and dental caries can be associated with 
several factors. Some of the most common 
risk factors include smoking, diabetes, 
autoimmune disorders, genetics, and obesity 
(14). The use of tobacco products remains 
the largest risk factor for periodontal 
disease. Environmental tobacco smoke 
has been associated with the increased 
likelihood of caries formation in children 
(2). Recent studies in this laboratory 
demonstrated increased biofilm formation 
of S. mutans with increasing nicotine 
concentrations (20). The average nicotine 
content in a single cigarette has been found 
in amounts up to 2 mg (12). A recent study 
tested over 40 smokeless tobacco products, 
such as snuff and chew, and it was 
discovered that they contained anywhere 
from 3.6-25.3 mg of nicotine per gram of 
smokeless tobacco (33). Nicotine contents 
of cigars have been found to vary greatly, 
ranging from 5.9 mg per cigar to 335.2 mg 
per cigar (18). Studies have demonstrated 
that when smoking cigarettes, an average 
of approximately 1 mg of nicotine per 
cigarette is absorbed by the body, however, 
the amount of nicotine within oral biofilm 
of smokers has not yet been explored (5). 
This study used the following opportunistic 
pathogens, commonly found in the human 
oral cavity, to investigate possible effects on 
growth and biofilm formation.
LACTOBACILLUS CASEI
Lactobacillus casei is a Gram-positive, 
facultative anaerobic bacterium. They are 
nonmotile and have a rod shape. Like other 
strains of lactobacilli, L. casei produces a 
significant amount of lactic acid, allowing it 
to remain viable under various pH levels. 
Poor diet, weak tooth enamel, previous 
plaque buildup, and acidic conditions 
contribute to an optimal environment 
for L. casei to thrive (22). L. casei alone 
lacks adequate strength to adhere to tooth 
enamel, however, when co-cultured with 
Streptococcus mutans, L. casei gains the 
ability to synthesize glucans thus improving 
tooth enamel adhesion. Because of this, L. 
casei along with S. mutans have been found 
to be the most prevalent bacteria leading to 
dental caries (19).
ACTINOMYCES VISCOSUS
Actinomyces viscosus is a facultative 
anaerobic, Gram-positive bacterium that is 
often isolated from the oral cavity, especially 
from subgingival plaque and along the teeth 
and gums. A. viscosus is rod-shaped and 
filamentous. Distinct characteristics of the 
filamentous shape include branching with 
swollen, rounded, or clavate ends (7). A. 
viscosus is a severely cariogenic bacterium 
that acts as an agent in promoting and 
initializing carious lesions (15). Studies have 
shown that the bacterium has adhesins 
which allow it to bind to complementary 
receptors on a substrate. A. viscosus binds to 
salivary acidic proline-rich proteins (PRPs) 
adsorbed onto the apatitic surfaces of the 
tooth. Cryptic segments exposed in adsorbed 
molecules are identified by the adhesins, 
which allow A. viscosus to efficiently attach 
to teeth while planktonically suspended in 
saliva (1).
ACTINOMYCES NAESLUNDII
Actinomyces naeslundii is a Gram-positive 
bacterium characterized by its rod shape 
and prominent fimbriae that allow it to 
bind to the tooth surface. A. naeslundii is 
facultatively anaerobic, nonmotile, non-
spore forming, and commonly grows in the 
oral cavity. (6) A. naeslundii is also a major 
component of dental plaque and it is known 
to cause dental caries, root canal infections, 
and periodontal disease (27). It is one of the 
specific species of the genus Actinomyces 
capable of causing the chronic bacterial 
infection, actinomycosis,
in humans (8).  A. naeslundii plays a role 
in actinomycosis by initiating infections 
in carious teeth, as well as causing 
infections in places where the mucosal 
integrity of the tooth is compromised (32). 
These infections are the precursor of the 
actinomycosis, however, the bacterium 
itself exhibits very low pathogenic 
properties.  These properties are enhanced 
by the presence of microorganisms such as 
species of Prevotella, Staphylococcus, and 
Streptococcus (35).
ROTHIA DENTOCARIOSA
Rothia dentocariosa is a facultative anaerobic, 
Gram-positive, pleomorphic bacterium that 
is commonly found in either filamentous 
or coccoid forms (24).  It is common in 
the oral cavity, and has been associated 
with many types of bacterial infections. 
Although R. dentocariosa was first isolated 
in dental caries, endocarditis is the most 
common infection caused by the organism. 
Cases have also been reported associating 
R. dentocariosa with intrauterine fetal death 
(16,25,28). R. dentocariosa is commonly 
associated with dental caries and periodontal 
disease. Studies have demonstrated the 
ability of R. dentocariosa to induce the 
release of TNF-a by macrophages, thereby 
eliciting inflammatory responses within the 
gingiva (36).
ENTEROCOCCUS FAECALIS
Enterococcus faecalis is a facultative 
anaerobic, Gram-positive cocci bacterium 
that is typically found in pairs or short 
chains. The most common locations for 
this microorganism in humans are the 
gastrointestinal tract, the vagina, and the 
oral cavity. E. faecalis is considered to 
be the most prevalent bacterium found 
in root canal infections (23). It is able to 
resist nutritional deprivation in part due 
to its ability to utilize a number of energy 
sources including malate, citrate, lactate, 
carbohydrates, and a number of amino 
acids. It is also able to withstand extremely 
basic environments, high salt concentrations, 
desiccation, and the presence of many 
antibiotics (17). These attributes allow 
E. faecalis to thrive in deep root canals. 
Additionally, scientists recently discovered 
E. faecalis has the ability to suppress 
lymphocyte function as well as produce 
lytic enzymes which aid in destruction of 
gingival tissues (9).
CANDIDA ALBICANS
Candida albicans is a ubiquitous 
pleomorphic fungus that colonizes the 
gastrointestinal, epithelial, and mucosal 
tissues of over 70% of the human 
population (26). Whether C. albicans takes 
on hyphal, pseudohyphal, or yeast form 
is dependent upon environmental factors 
such as temperature, pH, and presence 
of serum. C. albicans is an opportunistic 
pathogen that is often the cause of infection 
in immunocompromised patients, such 
as those with HIV/AIDS or indwelling 
medical devices. Imbalances in normal 
body flora due to antibiotic and steroid 
use have also been shown to provoke the 
overgrowth of Candida, causing candidiasis 
(21). Oral candidiasis, commonly known as 
thrush, can exacerbate already existing oral 
diseases. C. albicans has also been found 
within dental caries and is a contributor 
to periodontal disease (26). Many proteins 
within saliva have been found to promote 
adherence of C. albicans to gingival tissues 
(10). Additionally, tissues already colonized 
by streptococcal strains greatly enhance the 
ability of C. albicans to colonize the oral 
cavity (10).
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MICROBIAL STRAINS AND 
MEDIA
One yeast and five bacterial strains 
were utilized for this investigation. All 
microorganisms were obtained from 
the American Type Culture Collection 
(ATCC), Manassas, VA. The bacterial 
strains used were: Lactobacillus casei 
(ATCC 393), Rothia dentocariosa (ATCC 
17931), Enterococcus faecalis (ATCC 29212), 
Actinomyces naeslundii (ATCC 12104) and 
Actinomyces viscosus (ATCC 43146). The 
yeast strain used was Candida albicans 
(ATCC 10231). Four of the bacterial strains 
were grown in tryptic soy broth + 1% 
sucrose (TSBS; Difco Laboratories, Detroit, 
MI), while Actinomyces naeslundii was 
grown in brain heart infusion broth (BHI; 
Difco). All bacteria were incubated at 37°C 
in 5% CO2 for 24 or 48 hours. C. albicans 
was grown in yeast peptone dextrose 
broth (YPD; Difco) at 30°C in 5% CO2 for 
48 hours. The design of the experiment 
is consistent with other studies that have 
been both published and conducted in this 
laboratory (20).
MINIMUM INHIBITORY 
CONCENTRATION AND 
PLANKTONIC GROWTH 
QUANTIFICATION
Nicotine dilutions were prepared using 
a 1 g/ml nicotine stock solution (Sigma 
Chemical Co., St. Louis, MO) in TSBS or 
BHI for the bacteria and in YPD for the 
yeast. An initial dilution of 32 mg/ml 
of nicotine was prepared and a 1:2 serial 
dilution series was made through 0.25 mg/
ml. Additionally, a control was prepared 
containing only 200 μl of media with no 
nicotine. Diluted aliquots of 190μl were 
transferred into a sterile 96-well microtiter 
plate along with 10 μl of an overnight 
culture of the respective organism. The 
bacterial microtiter plates, excluding A. 
naeslundii, were incubated at 37°C in 5% 
CO2 for 24 hours and C. albicans and A. 
neaslundii were incubated under the same 
conditions for 48 hours. After incubation, 
the absorbance of each well in the plates 
was measured in a spectrophotometer 
(SpectraMax 190; Molecular Devices, Inc., 
Sunnyvale, CA) at an optical absorbance of 
595 nm (OD595) to determine the minimum 
inhibitory concentration (MIC). (20) To 
quantify the planktonic growth, 120μl 
aliquots of planktonic culture fluid was 
removed from each well into corresponding 
wells in a fresh 96-well microtiter plate 
and the absorbances determined in a 
spectrophotometer at 595 nm. Absorbance 
values greater than .05 units of the control 
would be considered a significant change. 
Anything equal or less to .05 absorbance 
units would be considered insignificant.
MINIMUM BIOFILM INHIBITORY 
CONCENTRATION
Ninety six-well plates of the organisms in 
varying concentrations of nicotine were 
prepared as described above. Following 
incubation, the remaining planktonic 
culture fluid was disposed of and 200μl 
of 10% formaldehyde (Fisher Scientific Co., 
Pittsburg, PA) was added to each well for 
30 minutes at room temperature. The plate 
was then washed in deionized (DI) water 
before adding 200μl of 0.3% crystal violet 
(Sigma) to each well. The plate was allowed 
to incubate for an additional 30 minutes 
and then washed in DI water. 200μL of 
isopropanol (Fisher) was then added to each 
well to allow extraction of the crystal violet 
from the biofilm cells. Following a one-hour 
incubation in isopropanol at
MATERIALS AND METHODS
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RESULTS
Table 1 indicates the MIC and MBIC of each 
microorganism tested. All organisms had 
an MIC of 16 mg/ml of nicotine except 
E. faecalis, which had an MIC of 32 mg/
ml of nicotine. Similarly, the MBIC of all 
organisms tested was 16 mg/ml of nicotine.
The total growth of the organisms in each 
nicotine concentration is presented in Fig. 1. 
This data represents the total of biofilm and 
planktonic growth. L. casei, A. viscosus, R. 
dentocariosa, and C. albicans had an increase 
in growth through 8 mg/ml of nicotine. E. 
faecalis growth increased through 16 mg/
ml but growth of all other organisms was 
decreased at this concentration of nicotine. A. 
naeslundii growth decreased through 8 mg/
ml and demonstrated complete inhibition 
beginning at 16 mg/ml. Additionally, all 
organisms displayed a decrease in total 
growth at 32 mg/ml of nicotine.
Fig. 2 denotes the planktonic growth of each 
organism in nicotine. Decreased growth 
occurred at 32 mg/ml of nicotine in all 
organisms tested. Additionally, L. casei, A. 
viscosus, and R. dentocariosa demonstrated 
statistically significant inhibition of 
planktonic growth at 16 mg/ml. An increase 
in growth occurred at 8 mg/ml of 
room temperature, the optical density of 
the biofilm was recorded at 490 nm. Using 
this method, both R. dentocariosa and A. 
naeslundii were unable to form tight biofilms 
in their 96-well plates. Therefore, instead of 
utilizing formaldehyde, crystal violet and 
isopropanol, the biofilm of R. dentocariosa 
and A. naeslundii were resuspended in 200μl 
of a 0.9% saline solution and the optical 
density was measured at 595 nm.
STATISTICAL ANALYSES
All experiments were carried out in 
quadruplicate wells at least three times. 
Means, standard deviations, and statistical 
significance were calculated using Excel. 
Student t-tests were used to determine p 
values, which were considered significant if 
P<0.05. Data was transferred to SigmaPlot 
12.0 to graph and further analyze results.
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Organisms
L. casei
A. viscosus
A. naeslundii
R. dentocariosa
E. faecalis
C. albicans
MIC (mg/ml)
16
16
16
16
16
32
MBIC (mg/ml)
16
16
16
16
16
16
Minimum inhibitory concentration (MIC) and 
minimum biofilm inhibitory concentration (MBIC) of 
nicotine on microorganisms
Table 1 Minimum inhibitory concentration (MIC) and 
minimum biofilm inhibitory concentration 
(MBIC) of nicotine on microorganisms
Fig. 1: Total growth of nicotine-treated microorganisms in quadruplicate wells.   After 
incubating with various concentrations of nicotine the OD was measured at 595 nm.  The 
OD value is represented as (mean + SD).  Each experiment was repeated at least three times.  
Asterisks indicate statistical significance (P< 0.05) compared to the 0 mg/ml nicotine control. 
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Fig. 2: Planktonic growth of nicotine-treated microorganisms in quadruplicate wells. 
After incubating with various concentrations of nicotine for 48 hours, the supernatant 
was removed and the OD of the supernatant was measured at 595 nm.  The OD value is 
represented as (mean + SD).  Each experiment was repeated at least three times.  Asterisks 
indicate statistical significance (P< 0.05) compared to the 0 mg/ml nicotine control.
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Fig. 3: Biofilm formation of nicotine-treated microorganisms in quadruplicate wells.  After 
incubating with various concentrations of nicotine for 24 or 48 hours, the biofilm was either 
stained with crystal violet or suspended in saline and the OD was assessed at 490 nm or 
595 nm, respectively.  The OD value is represented as (mean + SD).  Each experiment was 
repeated at least three times.  Asterisks indicate statistical significance (P< 0.05) compared to 
the 0 mg/ml nicotine control.
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Table 1 indicates the MIC and MBIC of each 
microorganism tested. All organisms had 
an MIC of 16 mg/ml of nicotine except 
E. faecalis, which had an MIC of 32 mg/
ml of nicotine. Similarly, the MBIC of all 
organisms tested was 16 mg/ml of nicotine.
The total growth of the organisms in each 
nicotine concentration is presented in Fig. 1. 
This data represents the total of biofilm and 
planktonic growth. L. casei, A. viscosus, R. 
dentocariosa, and C. albicans had an increase 
in growth through 8 mg/ml of nicotine. E. 
faecalis growth increased through 16 mg/
ml but growth of all other organisms was 
decreased at this concentration of nicotine. A. 
naeslundii growth decreased through 8 mg/
ml and demonstrated complete inhibition 
beginning at 16 mg/ml. Additionally, all 
organisms displayed a decrease in total 
growth at 32 mg/ml of nicotine.
Fig. 2 denotes the planktonic growth of each 
organism in nicotine. Decreased growth 
occurred at 32 mg/ml of nicotine in all 
organisms tested. Additionally, L. casei, A. 
viscosus, and R. dentocariosa demonstrated 
statistically significant inhibition of 
planktonic growth at 16 mg/ml. An 
increase in growth occurred at 8 mg/ml of 
nicotine for A. viscosus and R. dentocariosa. 
Moreover, E. faecalis planktonic growth 
was enhanced at 8 mg/ml and 16 mg/ml of 
nicotine. Significant inhibition was observed 
in 1 mg/ml of nicotine for A. viscosus and for 
4, 8, and 32 mg/ml of nicotine in C. albicans. 
A. naeslundii along with other bacteria in this 
study depict a high sensitivity to nicotine. 
The planktonic readings varied between 
trials, which made interpretations of 
planktonic response to nicotine inconsistent 
at times and difficult to interpret. 
Biofilm formation of the organisms in each 
nicotine concentration is indicated in Fig. 3. 
An upward trend in biofilm growth through 
8 mg/ml of nicotine was observed for L. 
casei, A. viscosus, E. faecalis, and C. albicans. 
R. dentocariosa exhibited the most growth 
at 1 mg/ml of nicotine but also had increased 
growth in 0.25, 2, and 8 mg/ml. Inhibition 
of biofilm formation for all organisms was 
indicated at 16 and 32 mg/ml of nicotine. 
Additionally, A. naeslundii demonstrated 
statistically significant inhibition beginning 
at 1 mg/ml and continuing through 32 mg/ml 
of nicotine.
DISCUSSION
Significant inhibition occurred with all 
tested organisms in nicotine concentrations 
of 16 and 32 mg/ml except E. faecalis, 
providing a MIC of 32 mg/ml for E. faecalis 
and a MIC of 16 mg/ml for the remaining 
organisms. Similar studies demonstrate 
other oral microorganisms, most notably 
S. mutans, also have a MIC of 16 mg/ml. 
(7)(20) It is possible that the MIC exists at 
nicotine concentrations between 8 and 16 
mg/ml but further studies are required to 
determine the validity of this supposition. 
Research by Huang et al. (2014) also 
demonstrated stimulatory effects by nicotine 
on Streptococcus gordonii (34). Another 
study investigating nicotine effects on 
oral microorganisms like Actinobacillus 
actinomycetemcomitans, Porphymonas 
gingivalis, Fusobacterium nucleatum and S. 
gordonii demonstrated no effect could be 
observed in concentrations less than 1 mg/
ml (13). The research conducted with these 
microorganisms is consistent with this study 
and demonstrates significant variations in 
activity at higher concentrations of nicotine. 
Alternatively, Pavia et al. (2000) were able 
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to demonstrate that nicotine concentrations 
between 100 and 250 ug/ml reduced growth 
of Escherichia coli, Listeria monocytogenes, 
Candida albicans, Klebsiella pneumoniae and 
Cryptococcus neoformans (27).
All concentrations of nicotine exerted some 
inhibition of planktonic growth, particularly 
at 16 and 32 mg/ml, when compared to the 
non-nicotine-treated controls for both L. casei 
and C. albicans. Previous research suggests 
that planktonic bacteria are more susceptible 
to various chemicals and antibiotics and so 
it is possible that the presence of nicotine 
induced this effect on the microorganisms 
studied (4). No reports were found on 
planktonic yeasts relating to chemical 
susceptibility, but it is plausible that similar 
effects as those observed in planktonic 
bacteria might also exist in yeast.  All species 
displayed planktonic inhibition at 32 mg/
ml. Furthermore, at concentrations of 16 mg/
ml both R. dentocariosa and L. casei were 
significantly inhibited. C. albicans growth 
was also inhibited in nicotine concentrations 
of 4 and 8 mg/ml. L. casei, A. viscosus, R. 
dentocariosa, E. faecalis, and C. albicans 
demonstrated no statistically significant 
differences in non-nicotine treated planktonic 
organisms compared to those treated with 
nicotine concentrations up to 2 mg/ml. A. 
viscosus, R. dentocariosa and E. faecalis 
had planktonic growth enhancement in 
concentrations of 16, 8, and 8 through 16 mg/
ml, respectively. All OD values measured 
from the planktonic growth were much 
lower than OD values recorded from biofilm 
growth. Visual analysis of the microtiter plates 
also signified greater biofilm growth when 
compared to planktonic growth. It is known 
that bacteria prefer existing in biofilms rather 
than as unicellular planktonic cells and it has 
been suggested that nearly 90% of bacteria 
exist as biofilms in nature. (31) The present 
study further supports this theory as well as 
extends the observation to C. albicans due to 
its perceived preference to grow as a biofilm 
rather than as a planktonic yeast phase. As 
Fig. 3 indicates, a notable upward trend in 
the biofilm formation of L. casei, A. viscosus, 
A. naeslundii, E. faecalis and C. albicans was 
demonstrated through 8 mg/ml of nicotine. 
Biofilm growth was most notably enhanced 
in 8 mg/ml of nicotine in the aforementioned 
organisms. R. dentocariosa presents a 
unique demonstration of enhancement in 
concentrations of nicotine ranging from 
0.25 to 8 mg/ml but was most prominently 
enhanced at 1 mg/ml. In addition, studies have 
shown that an increase in adhesion to surfaces 
occurs over time when C. albican, S. mutans, 
and S. pneumonaiae are exposed to cigarette 
smoke condensate (CSC). (4)(29) CSC is a 
crude aqueous extract of tobacco and contains 
approximately 2.4% nicotine by weight 
along with many other chemical components 
of tobacco. It is plausible that one of the 
attributing factors to the increase in adhesion 
is due to the nicotine contained within the 
CSC, which would thus account for the 
results observed in this study. Additionally, 
Antunes et al. 2012 (3) found that oxidative 
stress caused increased biofilm formation of 
P. aeruginosa. This study identified hydrogen 
peroxide as one causative agent of oxidative 
stress in cigarette smoke. Other research 
has indicated nicotine can also act as an 
oxidative stressor, which might account for 
the increased biofilm formation seen in many 
of the nicotine concentrations used in the 
current study (11). The MBIC of nicotine for 
all organisms studied was determined to be 
16 mg/ml as indicated in Fig. 3. As with the 
MIC, it is possible the MBIC also exists at 
some concentration between 8 and 16 mg/ml 
of nicotine, but further studies are needed to 
explore this probability.
In this present study, concentrations at 
which enhanced growth was demonstrated 
correspond to average nicotine 
concentrations found in many of the tobacco 
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products discussed previously. It is believed 
that the findings of this study support the 
hypothesis that the increased risk of oral 
health issues faced by many tobacco users 
is caused in part by the stimulation of 
oral microorganism biofilm formation by 
nicotine and other tobacco components. 
This study can be used to provide 
confirmation that further research on the 
relationship between oral microorganisms 
and nicotine is needed. Under similar 
growth conditions, the organisms could 
be exposed to nicotine intermittently 
throughout a specified length of time, much 
like how a smoker smokes periodically 
throughout the day. This study emulates 
the nicotine exposure which occurs to the 
oral flora of a smoker. Additionally, because 
microbes often exhibit different behaviors 
when interacting with multiple species, 
it would be beneficial to conduct a study 
which assesses the biofilm formation of 
multiple bacterial species in the mouth. 
This would more closely simulate an in 
vivo environment in an attempt to simulate 
dental caries, oral biofilm, periodontal disease 
and other diseases present in the mouth. 
Furthermore, investigating the types of 
interactions which occur between nicotine, 
proline-rich proteins, and bacteria would 
allow for a more thorough understanding of 
the specific mechanisms which cause biofilm 
enhancement in the presence of nicotine.
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